LadRx Corporation
LADX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.01 | 0.02 | -0.02 |
| FCF Yield | -157,538.42% | 159.69% | -105.86% | -65.74% |
| EV / EBITDA | -0.05 | 0.37 | -0.82 | -0.94 |
| Quality | ||||
| ROIC | 255.25% | -2,190.58% | -923.31% | -223.77% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 824.27 | 2.53 | 1.15 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -129,337.93% | 120.98% | 60.76% | -99.74% |
| Safety | ||||
| Net Debt / EBITDA | 0.48 | 0.53 | 0.27 | 0.48 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -67,521.29 | -37,091.80 | -23,741.64 | -38,402.35 |